Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause Intentional product misuse? 185 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Intentional product misuse have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.3% of all adverse event reports for LEFLUNOMIDE.

185
Reports of Intentional product misuse with LEFLUNOMIDE
0.3%
of all LEFLUNOMIDE reports
90
Deaths
141
Hospitalizations

How Dangerous Is Intentional product misuse From LEFLUNOMIDE?

Of the 185 reports, 90 (48.6%) resulted in death, 141 (76.2%) required hospitalization, and 103 (55.7%) were considered life-threatening.

Is Intentional product misuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 185 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause Intentional product misuse?

ETANERCEPT (3,992) PREGABALIN (3,731) BUDESONIDE\FORMOTEROL (3,399) ACETAMINOPHEN (2,924) ESOMEPRAZOLE (2,852) MINOXIDIL (2,418) TOFACITINIB (2,331) CINACALCET (2,092) QUETIAPINE (1,855) ALPRAZOLAM (1,709)

Which LEFLUNOMIDE Alternatives Have Lower Intentional product misuse Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All Intentional product misuse Reports All Drugs Causing Intentional product misuse LEFLUNOMIDE Demographics